Background: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used to improve glycemic control and induce weight loss in individuals with type 2 diabetes (T2D), yet treatment responses ...
Abstract: In recent years, diabetes has become a common disease that has affected people worldwide. Many factors make people have diabetes, like heavy body weight, increased cholesterol levels, lack ...
GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones ...
Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China Institute of Reproductive and Child Health, Key Laboratory of Reproductive Health, ...
New York, NY [August 28, 2025]—When genetic testing reveals a rare DNA mutation, doctors and patients are frequently left in the dark about what it actually means. Now, researchers at the Icahn School ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results